Elexacaftor/tezacaftor/ivacaftor treatment corrects the salt-losing phenotype in people with cystic fibrosis

Leipziger, Jens and Svendsen, Samuel and Rousing, Amalie Quist and Jensen-Fangel, Soren and Bandulik, Sascha and Warth, Richard and Sorensen, Mads Vaarby and Jeppesen, Majbritt and Berg, Peder (2023) Elexacaftor/tezacaftor/ivacaftor treatment corrects the salt-losing phenotype in people with cystic fibrosis. In: Physiology in Focus 2023 (SPS-FEPS 2023), 14-16 September, 2023, Tallinn, Estonia.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 500 Science > 570 Life sciences
600 Technology > 610 Medical sciences Medicine
Divisions: Biology, Preclinical Medicine > Institut für Physiologie > Prof. Dr. Richard Warth
Depositing User: Dr. Gernot Deinzer
Date Deposited: 13 Mar 2024 10:15
Last Modified: 13 Mar 2024 10:15
URI: https://pred.uni-regensburg.de/id/eprint/59613

Actions (login required)

View Item View Item